# IBSA Institut Biochimique SA – FDA Inspection, Mar 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/ibsa-institut-biochimique-sa/f6ac1d98-bfdc-4d34-9f34-e3f7b77dd3fd
Source feed: FDA_Inspections

> FDA inspection 1201222 of IBSA Institut Biochimique SA, March 24, 2023. Classification: Voluntary Action Indicated (VAI). 17 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201222
- Company Name: IBSA Institut Biochimique SA
- Inspection Date: 2023-03-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 17

## Related Documents

- FDA Inspection 1088003 - 2019-03-28
- [FDA Inspection 1056552 - 2018-06-22](https://www.keypedia.com/records/fda_inspections/ibsa-institut-biochimique-sa/d4e90c25-3a67-4af9-bf4c-558778c105de)
- FDA Inspection 981959 - 2016-07-08
- FDA Inspection 938124 - 2015-07-30
- FDA Inspection 853655 - 2013-09-27

## Related Officers

- [Miguel A. Martinez](https://www.keypedia.com/people/miguel-a-martinez/62e722b2-30bd-4671-9db9-8f089093e5a5)
- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)

Company: https://www.keypedia.com/companies/ibsa-institut-biochimique-sa/b4d0cf36-d7bc-4ea3-851a-9b0efe59255e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
